Product Information
HYDROCHLOROTHIAZIDE 12.5 MG CP is a generic product labeled by Actavis Pharma, Inc., priced at $0.0284 per EA under NDC 00591034701. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591034701
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020504On Market Since
12/27/1996
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 47.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0284 per EA |
|---|---|
| All-time high | $0.0731 (Feb 12, 2014) |
| All-time low | $0.0263 (Jul 17, 2024) |
| 52-week high | $0.0306 |
| 52-week low | $0.0284 |
| Median price | $0.0365 |
| Average price | $0.0398 |
| Largest weekly change | +21.9% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG CP, manufactured by Actavis Pharma, Inc., is $0.0284 per EA (NDC 00591034701), effective Jun 24, 2026.
How has the price of HYDROCHLOROTHIAZIDE 12.5 MG CP changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has declined 47.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG CP?
Since Nov 28, 2013, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has ranged from a low of $0.0263 (Jul 17, 2024) to a high of $0.0731 (Feb 12, 2014), with a median of $0.0365 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG CP?
10 NADAC-published products share the same active ingredient, strength, and dosage form as HYDROCHLOROTHIAZIDE 12.5 MG CP, but none are currently priced below it.
Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG CP?
HYDROCHLOROTHIAZIDE 12.5 MG CP (NDC 00591034701) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification